兆科眼科-B(06622.HK) 公布,环孢素A眼凝胶用于治疗中重度干眼症的第III期临床试验已于本月3日入组首名患者。
先前由公司进行的第III期研究(COSMO)结果显示,环孢素A眼凝胶最早可于两星期起效。通过每日一次用药及迅速起效,公司的环孢素A眼凝胶有望显著改善患者的用药依从性和生活质量。
(vc/u)
(港股报价延迟最少十五分钟。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.